Cardiometabolic disease is a composite term encompassing a constellation of health conditions that collectively heighten the risk of both cardiovascular disease and metabolic disorders, presenting a formidable health challenge in contemporary society. This intricate cluster includes maladies such as dyslipidemia, insulin resistance, and abdominal obesity, all of which synergistically contribute to an increased susceptibility to heart disease and related complications. The complex interplay of genetic factors, environmental influences, and individual behaviors underscores the multifactorial nature of cardiometabolic diseases. Unhealthy dietary patterns, sedentary lifestyles, and a genetic predisposition can collectively propel the onset and progression of these interconnected conditions. Timely identification and the implementation of comprehensive management approaches are paramount in curbing the impact of cardiometabolic diseases. Emphasis on lifestyle modifications, medication adherence, and routine health assessments becomes imperative in fostering improved outcomes. Public health campaigns dedicated to awareness, education, and preventive interventions emerge as key components in tackling the growing prevalence of cardiometabolic disease and fostering a healthier and more resilient population.
Title : Investigating the long-term follow up of atrial septal device closures in wales and england: A comparative analysis with major adverse cardiovascular Events (MACE)
Meera Gopinath, Cardiff University Medical school, United Kingdom
Title : An adult case of polysplenia syndrome associated with sinus node dysfunction
Apoorva Tripathi, Oxford University Hospitals, United Kingdom
Title : A unique cell-driven phenomenon in the heart and the promising future of the innovative translational tools to manage cardiac self-renewal and regeneration
Sergey Suchkov, N. D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences, Russian Federation
Title : Personalized and precision medicine (PPM) as a unique healthcare model through biodesign-driven translational applications and cardiology-related healthcare marketing to secure the human healthcare and biosafety
Sergey Suchkov, N. D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences, Russian Federation
Title : Yasser’s criterion of inferior ST-segment discrepancy deviations in AF with aberrancy and Sgarbosa criteria - a new cardiovascular discovery and management - a case report
Yasser Mohammed Hassanain Elsayed, Egyptian Ministry of Health, Egypt